These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 28671703)
1. Tetracycline-controllable artificial microRNA-HOTAIR + EZH2 suppressed the progression of bladder cancer cells. Chen Y; Xie H; Zou Y; Lai X; Ma L; Liu Y; Li J Mol Biosyst; 2017 Jul; 13(8):1597-1607. PubMed ID: 28671703 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription. Wang M; Guo C; Wang L; Luo G; Huang C; Li Y; Liu D; Zeng F; Jiang G; Xiao X Cell Death Dis; 2018 Feb; 9(2):238. PubMed ID: 29445179 [TBL] [Abstract][Full Text] [Related]
3. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of Long Noncoding RNA HOTAIR and EZH2 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells. Han L; Zhang HC; Li L; Li CX; Di X; Qu X Cancer Biother Radiopharm; 2018 Aug; 33(6):241-251. PubMed ID: 30048163 [TBL] [Abstract][Full Text] [Related]
5. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306 [TBL] [Abstract][Full Text] [Related]
6. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells. Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276 [TBL] [Abstract][Full Text] [Related]
7. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691 [TBL] [Abstract][Full Text] [Related]
8. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915 [TBL] [Abstract][Full Text] [Related]
9. Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells. Zhuang C; Li J; Liu Y; Chen M; Yuan J; Fu X; Zhan Y; Liu L; Lin J; Zhou Q; Xu W; Zhao G; Cai Z; Huang W Oncotarget; 2015 Dec; 6(38):41194-203. PubMed ID: 26517688 [TBL] [Abstract][Full Text] [Related]
10. LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression. Zhu F; Zhang X; Yu Q; Han G; Diao F; Wu C; Zhang Y J Cell Biochem; 2018 Jun; 119(6):4496-4505. PubMed ID: 29231261 [TBL] [Abstract][Full Text] [Related]
11. EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma. Li CH; Xiao Z; Tong JH; To KF; Fang X; Cheng AS; Chen Y Int J Cancer; 2017 Jan; 140(1):120-129. PubMed ID: 27594424 [TBL] [Abstract][Full Text] [Related]
12. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo. Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985 [TBL] [Abstract][Full Text] [Related]
13. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2. Liu D; Li Y; Luo G; Xiao X; Tao D; Wu X; Wang M; Huang C; Wang L; Zeng F; Jiang G Cancer Lett; 2017 Mar; 388():281-291. PubMed ID: 27998761 [TBL] [Abstract][Full Text] [Related]
14. Hotair mediates tumorigenesis through recruiting EZH2 in colorectal cancer. Huang KB; Zhang SP; Zhu YJ; Guo CH; Yang M; Liu J; Xia LG; Zhang JF J Cell Biochem; 2019 Apr; 120(4):6071-6077. PubMed ID: 30362162 [TBL] [Abstract][Full Text] [Related]
15. The role of long non-coding RNA HOTAIR in the progression and development of laryngeal squamous cell carcinoma interacting with EZH2. Zheng J; Xiao X; Wu C; Huang J; Zhang Y; Xie M; Zhang M; Zhou L Acta Otolaryngol; 2017 Jan; 137(1):90-98. PubMed ID: 27542077 [TBL] [Abstract][Full Text] [Related]
16. shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells. Li J; Zhuang C; Liu Y; Chen M; Zhou Q; Chen Z; He A; Zhao G; Guo Y; Wu H; Cai Z; Huang W Oncotarget; 2016 May; 7(20):28989-97. PubMed ID: 27015551 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HOTAIR promotes metastasis of renal cell carcinoma by up-regulating histone H3K27 demethylase JMJD3. Xia M; Yao L; Zhang Q; Wang F; Mei H; Guo X; Huang W Oncotarget; 2017 Mar; 8(12):19795-19802. PubMed ID: 28177890 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer. Li B; Xie F; Zheng FX; Jiang GS; Zeng FQ; Xiao XY J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):886-890. PubMed ID: 29270748 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2. Yang A; Wang H; Yang X Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046366 [TBL] [Abstract][Full Text] [Related]
20. Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells. Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]